載入...
Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma
BACKGROUND: Sunitinib is an approved treatment for metastatic renal cell carcinoma (mRCC). The safety profile and efficacy of sunitinib were confirmed in a global expanded access trial (ClinicalTrials.gov identifier: NCT00130897). This report presents a subanalysis of the final trial data from patie...
Na minha lista:
| 發表在: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045222/ https://ncbi.nlm.nih.gov/pubmed/27713637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S109445 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|